Malignant Catatonia: A Review for the Intensivist
Journal of Intensive Care Medicine · 2023-02 · 38 (2) · 137-150
DOI: 10.1177/08850666221114303 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Intensive Care Medicine, online erschienen am 21.07.2022. Verfasst von Jennifer Connell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Catatonia. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 99 Literaturangaben.
Abstract (Originalsprache)
Catatonia is a clinical syndrome characterized by psychomotor, neurological and behavioral changes. The clinical picture of catatonia ranges from akinetic stupor to severe motoric excitement. Catatonia can occur in the setting of a primary psychiatric condition such as bipolar disorder or secondary to a general medical illness like autoimmune encephalitis. Importantly, it can co-occur with delirium or coma. Malignant catatonia describes catatonia that presents with clinically significant autonomic abnormalities including change in temperature, blood pressure, heart rate, and respiratory rate. It is a life-threatening form of acute brain dysfunction that has several motoric manifestations and occurs secondary to a primary psychiatric condition or a medical cause. Many of the established predisposing and precipitating factors for catatonia such as exposure to neuroleptic medications or withdrawal states are common in the setting of critical illness. Catatonia typically improves with benzodiazepines and treatment of its underlying psychiatric or medical conditions, with electroconvulsive therapy reserved for catatonia refractory to benzodiazepines or for malignant catatonia. However, some forms of catatonia, such as catatonia secondary to a general medical condition or catatonia comorbid with delirium, may be less responsive to traditional treatments. Prompt recognition and treatment of catatonia are crucial because malignant catatonia may be fatal without treatment. Given the high morbidity and mortality associated with malignant catatonia, intensivists should familiarize themselves with this important and under-recognized condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Nashville, TN, USA.
- 12327Vanderbilt University School of Medicine, Nashville, TN, USA.
- University of Rochester Medical Center, Rochester, NY, USA.
- Division of Critical Care Medicine, Department of Anesthesiology, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
- Veterans Health Administration-Tennessee Valley Healthcare System Geriatric Research, Education and Clinical Center (GRECC), Nashville, TN, USA.
- Division of General Internal Medicine and Public Health, Department of Medicine, 12328Vanderbilt University Medical Center, Nashville, TN, USA.
ORCID-Profile: Jennifer Connell
Zitieren
APA
Connell, J., Oldham, M., Pandharipande, P., Dittus, R. S., Wilson, A., Mart, M., Heckers, S., Ely, E. W., & Wilson, J. E. (2023). Malignant Catatonia: A Review for the Intensivist. Journal of Intensive Care Medicine, 38(2), 137-150. https://doi.org/10.1177/08850666221114303
Vancouver
Connell J, Oldham M, Pandharipande P, Dittus RS, Wilson A, Mart M, et al. Malignant Catatonia: A Review for the Intensivist. Journal of Intensive Care Medicine. 2023;38(2):137-150. doi:10.1177/08850666221114303
BibTeX
@article{Connell2023,
author = {Connell, Jennifer and Oldham, Mark and Pandharipande, Pratik and Dittus, Robert S and Wilson, Amanda and Mart, Matthew and Heckers, Stephan and Ely, E Wes and Wilson, Jo Ellen},
title = {Malignant Catatonia: A Review for the Intensivist},
journal = {Journal of Intensive Care Medicine},
year = {2023},
volume = {38},
number = {2},
pages = {137--150},
doi = {10.1177/08850666221114303}
}
EUVIMED